Working Groups
In addition to the HCA committees, the HCA has the following Working Groups:
Working Groups
The Analysis Working Group (AWG) organises working groups, data analysis teams, meetings, jamborees, and recommends experimental designs, analysis frameworks and best practices for different aspects and needs of the HCA, from data collection to the Data Portal. The AWG is co-chaired by Dana Pe’er and John Marioni.
University of Toronto, Canada
Princeton University, USA
Harvard Medical School, USA
Memorial Sloan Kettering Cancer Institute, USA
New York Genome Center, USA
Wellcome Sanger Institute, UK
Weizmann Institute of Science, Israel
Helmholtz-Munich, Germany
UC Berkeley, USA
Analysis Working Group (AWG)
The Data Ecosystem Oversight Group (DEO) provides guidance to, and oversight of, all aspects of the HCA data ecosystem. This includes data ingestion and storage, the integration of datasets, cell type annotation, and the HCA Data Portal. The DEO ensures the coordination of these and other data ecosystem activities and recommends improvements to the HCA Organising Committee (OC). It also defines standards around data and metadata formats and recommends these standards to the OC for approval. The DEO is co-chaired by Chloe Villani and Shyam Prabhakar.
Mariana Boroni
Instituto Nacional de Câncer - INCA, Brazil
Wellcome Sanger Institute/Newcastle University, UK
Karolinska Institutet, Sweden
Michigan University, USA
Allen Institute, USA
University of Chile, Chile
Insitro, USA
Garvan Institute of Medical Research, Australia
Genome Institute of Singapore, Singapore
USA office
UK office
Massachusetts General Hospital, Harvard Medical School and Broad Institute, USA
Data Ecosystem Oversight Group (DEO)
The Ethics Working Group (EWG) has been set up to examine the ethical governance issues related to the HCA. The EWG does not provide legal opinions.
The role of the EWG includes:
- Discussing ethics-legal issues relevant to the HCA particularly in relation to its global reach;
- Providing input and commenting on ethics governance documents and tools related to the HCA.
The EWG reports to the HCA Organising Committee (OC). The EWG is an advisory group and is not responsible for decisions made with respect to the structure or governance of the HCA. The EWG is co-chaired by Bartha Knoppers, Barbara Wold and Roderic Guigo.
Broad Institute, USA
Fabiana Arzuaga
University of Buenos Aires, Argentina
NIH, USA
McGill University, Canada
The Netherlands
Wellcome Sanger Institute, UK
University of Edinburgh, UK
Broad Institute, USA
Stanford Law School, USA
Centre for Genomic Regulation, Spain
McGill University, Canada
McGill University, Canada
RIKEN, Japan
Wellcome Trust, UK
John C. Martin Centre for Liver Research & Innovations and Liver Foundation, West Bengal, India
Max Planck Institute for Comparative Public Law and International Law, Germany
University of Cape Town, South Africa
McGill University, Canada
Emanuelle Rial-Sebbag
Université de Toulouse, France
Andrea Saltzman
Broad Institute, USA
Caltech, USA
University of Cape Town, South Africa
Ethics Working Group (EWG)
The Equity Working Group (EqWG) aims to promote and support progress towards equity in the HCA. The EqWG seeks to engage the global community spanning diverse geographic and ethnic groups to drive inclusive representation and participation, and promote equal benefit from the HCA. The EqWG’s initial focus is on empowerment to participate in the HCA through outreach, education, and training. The EqWG is co-chaired by Alex Shalek, Partha Majumder and Musa M Mhlanga.
King Abdullah University of Science and Technology, Saudi Arabia, Middle East
WACCBIP - University of Ghana, Ghana, Africa
McGill University, Canada
Harry Perkins Institute of Medical Research, Australia
University of Sao Paulo, Brazil, South America
Wellcome Sanger Institute/Newcastle University, UK
McGill University, Canada
John C. Martin Centre for Liver Research & Innovations and Liver Foundation, West Bengal, India
Radboud University, The Netherlands
Genome Institute of Singapore, Singapore
Child Health Research Foundation, Bangladesh, Asia
MIT | Ragon | Broad, USA
University of Melbourne, Australia
Equity Working Group (EqWG)
The Diversity Task Force (DTF) will examine issues related to the tracking and sampling of diversity in HCA data. The DTF is co-chaired by Shyam Prabhakar, Kian Hong and Sophia George.
Icahn School of Medicine, USA
Ponpan Matangkasombut Choopong
Madihol University, Thailand
Arizona State University, USA
University of Edinburgh, UK
University of Miami, USA
NYU Abu Dhabi
Genome Institute of Singapore, Singapore
University of Chile, Chile
Garvan Institute, Australia
McGill University, Canada
Osaka University and University of Tokyo, Japan
Genome Institute of Singapore, Singapore
Albert Einstein Research and Education Institute, Brazil
Diversity Task Force (DTF)
The Standards and Technology Working Group (STWG) have two goals:
- bring together groups and centres to compare and disseminate existing methods; and
- ensure that new techniques are developed and adopted through a combination of academic efforts and the activities of technology companies that are eager to help the HCA and to learn from its collective expertise and experiences.
The STWG is co-chaired by Holger Heyn, Orit Rozenblatt-Rosen and Xiaowei Zhuang.
Broad Institute, USA
Fondazione Human Technopole, Italy & RIKEN, Japan
Cambridge University Hospitals, MRC Laboratory of Molecular Biology, Cambridge UK
Ludwig-Maximilians-University, Germany
Stanford University, USA
CNAG, Spain
Allen Institute, USA
Broad Institute, USA
KTH - Royal Institute of Technology, Sweden
Wellcome Sanger Institute, UK
University of Texas M.D. Anderson Cancer Center, USA
Stanford University, USA
Genentech, USA
Genentech, USA
Wellcome Cambridge Stem Cell Institute
KU Leuven, The Netherlands
Howard Hughes Medical Institute, USA and Harvard University, USA